TTM Technologies Inc.'s 10-K, read.

TTM is executing a high-growth acquisition strategy, growing H1 2026 revenues 34% YoY to $1.85B with operating margins improving to 9.8%, while maintaining strong cash generation. However, aggressive M&A (Epiq Solutions at $1.1B, STG, and Ophir Optics at $650M) coupled with significant new leverage ($1.3B incremental term loans, $500M senior notes) materially increases financial risk and execution complexity.

• Rapid increase in total debt to approximately $2.5B+ post-acquisitions against H1 2026 EBITDA of ~$245M, implying leverage above 10x and far exceeding 4.5x RCF covenant—substantial refinancing and deleveraging execution risk through 2027–28
• Three simultaneous major acquisitions (Epiq $1.1B, STG pending, Ophir $650M) with regulatory approvals required; integration complexity and synergy realization unproven; any failure or delay cascades to debt service
• H1 2026 foreign currency derivative loss of $14.0M (CHF/USD cross-currency swap for STG) signals unhedged acquisition risk; fair value losses could persist if CHF strengthens or deal closes late
• Operating margins compressed by acquisition-related charges ($4.9M in H1 2026); corporate overhead and amortization will spike post-deals, offset only if revenue synergies materialize quickly
• Customer concentration risk rising: Q1 2026 two customers = 26% of sales; larger, long-cycle defense customers could delay orders in uncertain macro; demand pullback would stress high debt service requirements

Not investment advice — general research, the same for every reader. You make your own calls.